Rheumatoid Factor Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Rheumatoid Factor Antibodies for research in rheumatoid arthritis and related autoimmune disorders. Rheumatoid Factor Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rheumatoid factor is an autoantibody that targets the Fc region of immunoglobulin G (IgG), playing a significant role in the pathogenesis of rheumatoid arthritis. The presence of rheumatoid factor is often associated with disease severity and can provide insights into the underlying mechanisms of autoimmune responses. Understanding the function and regulation of rheumatoid factor is crucial for developing targeted therapies and improving patient outcomes. Research focused on rheumatoid factor has revealed important connections between immune system dysfunction and inflammatory responses. Investigating the molecular mechanisms of rheumatoid factor can lead to better diagnostic tools and treatment strategies. Current studies continue to uncover new aspects of rheumatoid factor's role in disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing the understanding of autoimmune diseases and developing innovative therapeutic approaches.